Actinium chelation and crystallization in a macromolecular scaffold.

Targeted alpha therapy (TAT) pairs the specificity of antigen targeting with the lethality of alpha particles to eradicate cancerous cells. Actinium-225 [225Ac; t1/2 = 9.920(3) days] is an alpha-emitting radioisotope driving the next generation of TAT radiopharmaceuticals. Despite promising clinical results, a fundamental understanding of Ac coordination chemistry lags behind the rest of the Periodic Table due to its limited availability, lack of stable isotopes, and inadequate systems poised to probe the chemical behavior of this radionuclide. In this work, we demonstrate a platform that combines an 8-coordinate synthetic ligand and a mammalian protein to characterize the solution and solid-state behavior of the longest-lived Ac isotope, 227Ac [t1/2 = 21.772(3) years]. We expect these results to direct renewed efforts for 225Ac-TAT development, aid in understanding Ac coordination behavior relative to other +3 lanthanides and actinides, and more broadly inform this element's position on the Periodic Table.

Photocatalytic dechlorination of unactivated chlorocarbons including PVC using organolanthanide complexes.

Simple lanthanide cyclopentadienyl (Cp) complexes can photochemically cleave the sp3 carbon-chlorine bond of unactivated chlorinated hydrocarbons including polyvinyl chloride (PVC). The excited state lifetimes of these simple complexes are among the longest observed for cerium complexes (175 ns for [(CpMe4)2Ce(µ-Cl)]2) and the light absorption by the Cp ligand is efficient, so photocatalytic reactivity is enhanced for cerium and now also made possible for neighboring, normally photoinactive, lanthanide congeners.

Macrocyclic 1,2-Hydroxypyridinone-Based Chelators as Potential Ligands for Thorium-227 and Zirconium-89 Radiopharmaceuticals.

Thorium-227 (227Th) is an α-emitting radionuclide that has shown preclinical and clinical promise for use in targeted α-therapy (TAT), a type of molecular radiopharmaceutical treatment that harnesses high energy α particles to eradicate cancerous lesions. Despite these initial successes, there still exists a need for bifunctional chelators that can stably bind thorium in vivo. Toward this goal, we have prepared two macrocyclic chelators bearing 1,2-hydroxypyridinone groups. Both chelators can be synthesized in less than six steps from readily available starting materials, which is an advantage over currently available platforms. The complex formation constants (log ßmlh) of these ligands with Zr4+ and Th4+, measured by spectrophotometric titrations, are greater than 34 for both chelators, indicating the formation of exceedingly stable complexes. Radiolabeling studies were performed to show that these ligands can bind [227Th]Th4+ at concentrations as low as 10-6 M, and serum stability experiments demonstrate the high kinetic stability of the formed complexes under biological conditions. Identical experiments with zirconium-89 (89Zr), a positron-emitting radioisotope used for positron emission tomography (PET) imaging, demonstrate that these chelators can also effectively bind Zr4+ with high thermodynamic and kinetic stability. Collectively, the data reported herein highlight the suitability of these ligands for use in 89Zr/227Th paired radioimmunotheranostics.

Defining Stereochemistry in the Polymerization of Lactide by Aluminum Catalysts: Insights into the Dual-Stereocontrol Mechanism.

Aspects of the proposed pathway combining chain-end and enantiomorphic site control for the stereospecific polymerization of lactide (LA) were investigated through studies of aluminum complexes supported by enantiopure and racemic bipyrrolidine-based salan ligands, Lig1AlOBn and Lig2AlOBn. Spectroscopic analysis of stoichiometric initiation reactions and the definition of the stereochemistry of the selective formation of the "match" single-insertion products by X-ray crystallography led to key conclusions about the observed stereocontrol. Notably, it was determined to rely heavily on the preference for the trio of stereocenters around the metal to have a "match" formation (RR-ligand + S-polymer), which works synergistically with the enantiomorphic site preference of the catalyst to ring-open next to a stereocenter of a monomer of the same chirality as that of the ligand, resulting in highly heterotactic or syndiotactic PLA from rac- or meso-LA, respectively.